Related Experiment Video
Updated: Sep 5, 2025

09:42
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
7.5K
Improvement of atopic dermatitis and alopecia universalis with dupilumab
Lama Alotaibi1, Abdulrahman Alfawzan2, Raghad Alharthi2
1Division of Dermatology, Department of Medicine, Prince Sultan Military Medical City, Riyadh.
Dermatology Reports
|July 7, 2022
Abstract:
Dupilumab is an interleukin-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis and alopecia totalis after dupilumab treatment for AD. We present one of reported cases that showed improvement of underlying alopecia universalis treated with dupilumab.

